Global Proteins & Protein Crystals Market Projected to Reach $960 Billion by 2030, Driven by Biopharmaceutical R&D and Structural Biology Advances
核心洞察
The global proteins and protein crystals market is forecast to grow from $609.51 billion in 2025 to $960.37 billion by 2030, reflecting a compound annual growth rate of 9.5%.
Structural proteins are expected to record the highest growth rate, fueled by demand in drug discovery, structural biology, and regenerative medicine applications.
The healthcare application segment leads market expansion, driven by rising demand for therapeutic proteins, monoclonal antibodies (搜索), vaccines (搜索), and diagnostic enzymes.
The global market for proteins and protein crystals is on track to reach an estimated USD 960.37 billion by 2030, up from USD 609.51 billion in 2025, representing a compound annual growth rate (CAGR) of 9.5% over the forecast period, according to a new report from ResearchAndMarkets.com. The findings underscore the expanding role of protein-based technologies across biopharmaceutical development, structural biology, diagnostics, and industrial applications.
Key industry drivers identified in the report include increasing demand for biopharmaceuticals, heightened research and development activity in structural biology and drug discovery, and the broadening use of proteins across therapeutic, diagnostic, and industrial sectors. Enzymatic proteins currently dominate the market, owing to their extensive application in therapeutics, industrial biocatalysis, and high-throughput screening. Recombinant and monoclonal proteins are also gaining significant traction in drug development and personalized medicine, valued for their specificity and scalability.
Structural Proteins Poised for Fastest Growth
The structural proteins segment is expected to record the highest CAGR during the 2025–2030 forecast period. This growth is propelled by demand across research, healthcare, and industrial domains. Proteins such as actin and tubulin play critical roles in structural biology, high-throughput crystallography, and drug discovery. Membrane proteins, in particular, are emerging as key therapeutic targets for developing biologics and precision medicine. Additionally, connective tissue and extracellular matrix proteins—including collagen, elastin, laminins, and proteoglycans—are driving demand in biomaterials, tissue engineering, regenerative medicine, and cosmetic products.
Healthcare Applications Lead Market Expansion
The healthcare application segment accounts for the highest CAGR among all end-use categories. This growth is closely linked to rising demand for therapeutic proteins, monoclonal antibodies (搜索), vaccines (搜索), and diagnostic enzymes. The increasing prevalence of chronic diseases (搜索), cancer (搜索), and metabolic disorders (搜索) continues to spur development of protein-based biologics. Advances in structural biology and protein crystallography are further accelerating drug discovery and targeted therapy efforts, the report notes.
Asia Pacific Emerges as Fastest-Growing Region
Geographically, the Asia Pacific region is set to exhibit the highest CAGR, fueled by robust expansion across healthcare, research, and additional application areas. Growing biopharmaceutical R&D investment, a rising burden of chronic disease, and the adoption of personalized medicine are driving demand for therapeutic proteins, monoclonal antibodies (搜索), and protein-based diagnostics. Enhanced life sciences infrastructure, the proliferation of Contract Research Organizations (CROs), and structural biology initiatives are boosting usage of protein crystallization kits and reagents in both research and academic settings.
Beyond healthcare, the report highlights expanding applications in agriculture and animal health—where proteins are utilized for feed additives, vaccines (搜索), and disease management—as well as in cosmetics, where structural proteins like collagen and elastin feature prominently in anti-aging and skincare products. In the bioenergy sector, enzymes facilitate biomass conversion and biofuel production, collectively contributing to rapid market growth in the Asia Pacific region.
Market Dynamics: Drivers, Restraints, and Opportunities
The report identifies several forces shaping the market landscape. On the driver side, increasing emphasis on structure-based drug discovery and development, rising demand for protein-based drug development, growing need for therapeutic proteins, and technological advancements in crystallization methods are propelling growth.
Key restraints include high technical complexity and low success rates in protein crystallization, concerns regarding ionizing radiation exposure among vulnerable populations, and the substantial costs, technical expertise, and advanced infrastructure required for commercialization.
Opportunities lie in the integration of AI-enabled innovations, collaboration between academia and industry, and high investment and funding in structural biology, biopharmaceuticals, and advanced drug development. Meanwhile, challenges persist around reproducibility issues in protein crystallization and scalability concerns in recombinant protein production.
Key Market Players
Major companies profiled in the report include Danaher Corporation (搜索), Thermo Fisher Scientific (搜索), Sanofi, Agilent Technologies (搜索), Takeda Pharmaceutical (搜索), International Flavours & Fragrances, Biocon, RayBiotech (搜索), Merck KGaA, Amgen, Eli Lilly, Roche, Novo Nordisk, and Pfizer, among others. The report provides a comprehensive analysis segmented by product type, application, end-user, and region, offering micro-level insights into market trends and growth opportunities across major global regions.